title: Heart transplantation: La Pitié experience, 1968-1989.
abstract: Heart transplantation is now an accepted therapeutic modality for end-stage heart disease. However, better immunosuppressive treatments and new methods to monitor rejection or detect early atherosclerosis must be developed to improve the long-term results after heart transplantation.
authors.affiliation: La Pitié Hospital, Paris, France.
authors.forename: A
authors.initials: A
authors.lastname: Miralles
authors.forename: I
authors.initials: I
authors.lastname: Gandjbakhch
authors.forename: A
authors.initials: A
authors.lastname: Pavie
authors.forename: J
authors.initials: J
authors.lastname: Szefner
authors.forename: M
authors.initials: M
authors.lastname: Desruennes
authors.forename: A
authors.initials: A
authors.lastname: Cabrol
authors.forename: P
authors.initials: P
authors.lastname: Leger
authors.forename: E
authors.initials: E
authors.lastname: Vaissier
authors.forename: L
authors.initials: L
authors.lastname: Bracamonte
authors.forename: J P
authors.initials: JP
authors.lastname: Levasseur
mesh_terms: D009202:Cardiomyopathies / Q000601:surgery; D003327:Coronary Disease / Q000601:surgery; D003524:Cyclosporins / Q000009:adverse effects / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection; D016027:Heart Transplantation / Q000276:immunology; D006349:Heart Valve Diseases / Q000601:surgery; D006801:Humans; D007165:Immunosuppression Therapy
chemical_list: D003524:Cyclosporins